Skip to main navigation
Leap therapeutics
Leap therapeutics
  • About
    • About
    • Contact Us
  • Pipeline
    • Pipeline
    • Sirexatamab (DKN-01) Programs
      • Gastric Cancer
      • Colorectal Cancer
      • Endometrial Cancer
      • Prostate Cancer
      • Lung Cancer
    • FL-501 Program
  • Science
    • Science
    • DKK1
    • Sirexatamab (DKN-01)
    • GDF15
  • Patients
    • Patients
    • Expanded Access
  • Careers
  • Investors
    • Investors
    • Stock Information
    • News Releases
    • Presentations & Events
    • Financial Information
    • Corporate Governance
    • Information Request

Investors

image description
  • Stock Information
  • News Releases
  • Presentations & Events
  • Financial Information
  • Investor Resources

Investors

Recent News

Aug 12, 2026
Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
Aug 12, 2026
Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
Oct 20, 2025
Leap Therapeutics Presents Final Data from DeFianCe Study at ESMO 2025
View All

Upcoming Events

There are no upcoming events at this time.

View All

Past Events

Oct 20, 2025
ESMO 2025 Recording: Dr. Zev Wainberg Presents Final Data from the DeFianCe Study
Jun 18, 2025 at 11:30 AM EDT
2025 Annual Meeting
Apr 23, 2025 at 2:30 PM EDT
Virtual KOL Event to Discuss Sirexatamab (DKN-01) in Second-line Patients with Advanced Microsatellite Stable (MSS) Colorectal Cancer (CRC)
View All
  • image Print Page Print Page
  • image Email Alerts Email Alerts
  • image Contact Us Contact Us
image description
image description
Leap therapeutics
47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA
+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

  • ABOUT
  • CONTACT US
  • CAREERS
  • PIPELINE
  • Sirexatamab (DKN-01) Programs
  • FL-501 Program
  • PATIENTS
  • EXPANDED ACCESS
  • SCIENCE
  • DKK1
  • Sirexatamab (DKN-01)
  • GDF-15
  • INVESTORS
  • STOCK INFORMATION
  • NEWS RELEASES
  • PRESENTATIONS & EVENTS
  • FINANCIAL INFORMATION
  • CORPORATE GOVERNANCE
  • INFORMATION REQUEST
  • © 2026 Leap Therapeutics, Inc.
  • All Rights Reserved.
  • Terms of Use
  • Privacy Policy
  • Cookie Policy